Long-term Health After Severe Acute Malnutrition in Children and Adults: the Role of the Pancreas
NCT ID: NCT05361148
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2305 participants
OBSERVATIONAL
2021-01-12
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators wish to focus on the pancreas which is a key organ in digestion and metabolic processes, especially in relation to diabetes. They will investigate pancreas size, microscopic structure, hormone and digestive enzyme production, and the body's response to these hormones among groups of people in Tanzania, Zambia, India and the Philippines. These groups have participated in the research team's previous studies of malnutrition and were malnourished before birth, as children, or as adults. They now live in places with a wide range of access to foods high in fat and sugar which could affect their risk of diabetes. The investigators will compare their pancreas function to that of never-malnourished controls at each site. The investigators will use advanced statistical methods to understand the links between early malnutrition and later diabetes, taking into account the factors often associated with diabetes such as age, current overweight and infection.
Even if the investigators find no important link between early malnutrition and later diabetes, the research will lead to improved understanding of the long-term consequences of malnutrition and the presentation and underlying metabolism of diabetes in Africa and Asia. Thus, the project will lead to improved health care for both malnourished and diabetic people.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism
NCT03090347
The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and Metabolism
NCT03145350
Weight Gain and Adipose Tissue
NCT02703766
The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose Tissue
NCT02482519
Short-term Fat Overfeeding on the Effects of Liver Metabolism
NCT05962190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Overall hypothesis:
Severe malnutrition (MALN) at any age has medium- and long-term detrimental effects on endocrine and exocrine pancreatic function and structure.
Study design and population: Cross-sectional observational study recruiting a total of 3700 participants from previous/ongoing observational cohorts in: Zambia (1 adult (N=300) and 1 adolescent cohort (N=180)), Tanzania (1 adult cohort (N=1400)), Philippines (2 adult cohorts N=600/N=420), India (1 adolescent low birth weight cohort N=800))
Specific objective 1: To determine if MALN earlier in life is associated with abnormalities of pancreas structure and function.
Hypothesis 1: Prior MALN is associated with later abnormal pancreatic structure and endocrine and exocrine function.
Approach: The investigators will follow up individuals from the above cohorts in which there are participants, all now adolescents or adults, who suffered from MALN at different stages earlier in life as well as age- and sex-matched individuals who have never been malnourished as a comparison. The researchers will assess in those with and without prior MALN:
1. blood glucose, insulin and C-peptide during an oral glucose tolerance test (OGTT)
2. haemoglobin A1c (HbA1c)
3. faecal elastase and plasma lipase as exocrine pancreas markers
4. pancreas size and architecture using ultrasound and computed tomography (CT) (subset)
Specific objective 2: To investigate whether pancreatic abnormalities in participants with prior MALN and diabetes are compatible with a previously prescribed entity of fibro-calculous diabetes.
Hypothesis 2: Prior MALN is associated with pancreatic calcifications and is common in those with diabetes.
Approach: The investigators will conduct CT scans to investigate pancreatic calcification among non-pregnant adult study participants.
Specific objective 3: To investigate the relative importance of decreased insulin production or increased insulin resistance in MALN associated with concurrent infections in African and Asian adult populations.
Hypothesis 3: The abnormal glucose regulation seen after MALN and infection is associated with relative insulin deficiency with or without insulin resistance.
Approach: This hypothesis will be investigated within the Tanzanian cohort and one Filipino adult cohort, both of whom had MALN associated with infection. 20 men and 20 women will be selected from each of two groups (MALN and non-MALN) in each cohort based on whether or not in our prior research they were recorded as experiencing MALN. In these participants the investigators will:
1. Measure in blood samples collected at 0, 15, 30, 45, 60, 90 and 120 minutes during an OGTT: glucose, insulin, C-peptide (all time points), the incretins gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) and glucagon at 0, 30, 60, 90 and 120 minutes, and proinsulin and trypsinogen at baseline only;
2. Conduct intravenous glucose tolerance tests (IVGTT) and measure in blood samples collected at -10, -1, 2, 4, 6, 8, 10 minutes: glucose, insulin, and C-peptide.
Specific objective 4: To investigate whether a prior abnormal pro-insulin / insulin ratio is associated with diabetes in adults infected with HIV or previously with tuberculosis.
Hypothesis 4: An abnormal pro-insulin/insulin ratio is associated with later development of diabetes in adults who had MALN and infection.
Approach: For participants from the CICADA, Tanzania, cohort the reasearch team has fasting plasma samples stored from prior follow-ups up to 10 years earlier. Glucose has already been measured in these samples as well as insulin in some samples. The investigators will measure insulin in the remaining stored samples and proinsulin in all to investigate whether prior proinsulin / insulin ratio is associated with subsequent diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DIVIDS (Delhi Infant Vitamin D Supplementation) study, India
The DIVIDS cohort were born low birth weight (LBW, \<2.5 kg) at term in 2007-2010. They had monthly follow-up until 6m then at 5 and 11 years. Anthropometry was collected at all visits, body composition in the 5 and 11 years, and blood samples at 6 months and 5 and 11 years. For SAMPA, the DIVIDS cohort acts as a positive control since we expect adverse long-term non-communicable disease consequences of being born LBW.
Sample numbers at previous follow-ups and expected:
* Birth: 2079 total, all LBW
* Age 5 y: 911 total, 764 (84%) BMIZ\>-2, 138 (15%) BMIZ -2 to -3, 9 (1%) BMIZ\<-3
* Age 11 y (ongoing): 647 total, 482 (75%) BMIZ\>-2, 117 (18%) BMIZ -2 to -3, 48 (7%) BMIZ\<-3
* Expected for SAMPA: 800 total
no interventions will be used
This is a cohort study with no interventions.
SAM (Severe Acute Malnutrition) Lusaka
This group comprises children with or without prior MALN in early childhood. Some are from a study which identified 1195 children with MALN (mean age 16 months, 11.6% HIV-infected) in a house-to-house survey in a low-income area, Misisi, Lusaka in 2009. Some children are from a study of body composition and indicators of chronic diseases (HbA1c, lipids); 100 were hospitalised with MALN when \< 2 years and 76 are never-malnourished neighbourhood controls.
Sample numbers at previous follow-ups and expected:
* Age \< 2 y: 400 total, 200 WHZ\<-3, 200 well-nourished
* Age 9 y: 186 total, 110 previous MALN, 76 no MALN; currently 17 (9%) BMIZ \<-2
* Expected for SAMPA: 400 total
no interventions will be used
This is a cohort study with no interventions.
CICADA (Chronic Infections, Co-morbidities and Diabetes in Africa), Mwanza, Tanzania
The CICADA cohort comprises HIV-infected and uninfected recruited since 2010. CICADA involved 3 annual visits for data on HbA1c, OGTT, insulin, anthropometry, body composition, and diabetes lifestyle risk factors. CICADA has the most detailed longitudinal diabetes data of the project cohorts, archived fasting samples, and are the oldest so have had longer to develop diabetes; therefore, this cohort will be used for the in-depth and longitudinal components (hypotheses 3 and 4).
Sample numbers at previous follow-ups and expected:
* 12 y prior: 447 total, 300 (67%) BMI \> 18.5 kg/m2, 74 (17%) BMI 17 to 18.5 kg/m2 73 (16%) BMI \<17 kg/m2
* 10 y prior: 704 total, 304 (43%) BMI 17 to 18.5 kg/m2, 400 (57%) BMI\<17 kg/m2
* 3 y prior: 1947 total, 1519 (78%) BMI \> 18.5 kg/m2, 275 (14%) BMI 17 to18.5 kg/m2, 152 (8%) BMI \<17 kg/m2
* Expected for SAMPA: 1200 total
no interventions will be used
This is a cohort study with no interventions.
NUSTART Lusaka
We will trace and recruit 200 previously malnourished HIV-infected adults from the NUSTART Lusaka participants plus 100 non-HIV-infected neighbourhood controls to the SAMPA study. As for NUSTART Mwanza, there was a high mortality rate during the first 12 weeks of ART.
Sample numbers at previous follow-ups and expected:
* 10 y prior: 1111 total, 437 (39%) BMI 17 to 18.5 kg/m2, 674 (61%) BMI\<17 kg/m2
* Expected for SAMPA: 300 total
no interventions will be used
This is a cohort study with no interventions.
St-ATT (Starting Anti-TB Treatment) Cohort, Philippines
Between Aug 2018 and Feb 2020, the St-ATT cohort recruited 900 adults within 5 days of starting a new 6 or 9 month anti-TB regimen in three provinces: Cebu, Negros Occidental and Metro Manila, encompassing urban, peri-urban and rural populations. 17% had HbA1c \>=7.0% (probable diabetes in TB) with an additional 30% with HbA1c 5.8%-7.0% ('prediabetes'/mild TB-induced hyperglycaemia). Post-treatment follow-up is ongoing. This cohort will be involved in in-depth analyses for hypothesis 3.
Sample numbers at previous follow-ups and expected:
* 1-2 y prior: 900 total, 495 BMI \>18.5 kg/m2, 189 (21%) BMI 17.0 -18.5 kg/m2, 216 (24%) BMI \<17 kg/m2
* Expected for SAMPA: 600 total
no interventions will be used
This is a cohort study with no interventions.
CLHNS (Cebu Longitudinal Health and Nutrition Survey), Philippines
The cohort was recruited in 1983-84. Since the original follow-up to age 2 years, there have been 8 follow-up surveys including in 2019 when 1300, \~40% of the initial cohort, were available. Loss from the cohort over time is mostly from out-migration and those remaining are more rural and of lower socioeconomic status. In follow-up surveys, data collection included: anthropometry, diet (24-hr recall), health history, blood pressure and other chronic disease risk factors, school achievement, and, for older ages, reproductive history. This cohort represents our longest follow-up of MALN diagnosed by anthropometry resulting primarily from poor nutrition, not specific severe infections.
Sample numbers at previous follow-ups and expected:
* Birth: 28 LBW of the 144 with childhood MALN
* Age \< 2 y: of 420 total to be included, 144 (34%) WHZ\<-3
* Expected for SAMPA: 420 total
no interventions will be used
This is a cohort study with no interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no interventions will be used
This is a cohort study with no interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent (for children, informed assent and consent of guardian)
Exclusion Criteria
* pregnant women and chidlren will be excluded from CT scans and interavenous glucose tolerance tests
8 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Newcastle University, UK
UNKNOWN
University of Copenhagen
OTHER
National Institute for Medical Research, Tanzania
OTHER_GOV
Nutrition Centre of the Philippines
UNKNOWN
University Teaching Hospital, Lusaka, Zambia
OTHER
Delhi University
OTHER
London School of Hygiene and Tropical Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suzanne Filteau, PhD
Role: PRINCIPAL_INVESTIGATOR
London School of Hygiene and Tropical Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Home Economics Delhi University
Delhi, , India
Nutrition Centre of the Philippines
Cebu City, , Philippines
National Institute for Medical Research
Mwanza, , Tanzania
University Teaching Hospital
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPPHZU29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.